Strain- and growth condition-dependent variability in outer membrane protein expression by Bordetella bronchiseptica isolates from dogs

American Journal of Veterinary Research

Volumn 60, Issue 8, 1999, Pages 1016-1021

  Keil, Daniel J ^a   Fenwick, Brad ^a  

^a KANSAS STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL VACCINE; BORDETELLA VIRULENCE FACTOR; HEMAGGLUTININ; OUTER MEMBRANE PROTEIN; PERTACTIN;

ANIMAL; ANIMAL DISEASE; ARTICLE; BACTERIAL INFECTION; BIOSYNTHESIS; BLOOD; BORDETELLA BRONCHISEPTICA; COMPARATIVE STUDY; DOG; DOG DISEASE; FEMALE; GENE EXPRESSION REGULATION; GENETICS; GERMFREE ANIMAL; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; RABBIT;

ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL VACCINES; BORDETELLA BRONCHISEPTICA; BORDETELLA INFECTIONS; DOG DISEASES; DOGS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; GENE EXPRESSION REGULATION, BACTERIAL; HEMAGGLUTININS; RABBITS; SPECIFIC PATHOGEN-FREE ORGANISMS; VIRULENCE FACTORS, BORDETELLA;

EID: 0033175996     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Bemis DA, Greisen HA, Appel MJG. Pathogenesis of canine bordetellosis. J Infect Dis 1977;135:753-762.
2. Savelkoul PH, de Kerf DP, Willems RJ, et al. Characterization of the fim2 and fim3 fimbrial subunit genes of Bordetella bronchiseptica: roles of Fim2 and Fim3 fimbriae and flagella in adhesion. Infect Immun 1996;64:5098-5105.
3. Register KB, Ackermann MR. A highly adherent phenotype associated with virulent Bvg* phase swine isolates of Bordetella bronchiseptica grown under modulating conditions. Inject Immun 1997;65: 5295-5300.
4. Bemis DA, Kennedy JR. An improved system for studying the effect of Bordetella bronchiseptica on the ciliary activity of canine tracheal epithelial cells. J Infect Dis 1981;144:349-357.
5. Thomas MG, Redhead K, Lambert HF Human serum antibody response to Bordetella pertussis infection and pertussis vaccination. J Inject Dis 1989;159:211-218.
6. Montaraz JA, Novotny P, Ivanyi J. Identification of a 68-kilodalton protective antigen from Bordetella bronchiseptica. Infect Immun 1985;47:744-751.
7. Kasprzak H, Rehak E, Kruger M. Influence of culture conditions on expression of antigens in Bordetella bronchiseptica. J Vet Med 1994;41:645-653.
8. Cotter PA, Miller JF. A mutation in the Bordetella bronchiseptica bvgS gene results in reduced virulence and increased resistance to starvation, and identifies a new class of Bvg-regulated antigens. Mol Microbiol 1997;24:671-685.
9. Cotter PA, Miller JE BvgAS-mediated signal transduction: analysis of phase-locked regulatory mutants of Bordetella bronchiseptica in a rabbit model. Infect Immun 1994;62:3381-3390.
10. Carter GR, Chengappa MM, Roberts AW. Bordetella and moraxella In: Carter GR, Chengappa MM, Roberts AW, eds. Essentials of veterinary microbiology. 5th ed. Baltimore: The Williams & Wilkins Co, 1995;194-198.
11. Stainer DW, Scholte MJ. A simple chemically defined medium for the production of phase I Bordetella pertussis. J Gen Microbiol 1971;63:211-220.
12. Squire PG, Smiley DW, Croskell RB. Identification and extraction of Pasteurella haemolytica membrane proteins. Infect Immun 1984; 45:667-673.
13. Gatewood DM, Fenwick BW, Chengappa MM. Growth-condition dependent expression of Posteurella haemolytica A1 outer membrane proteins, capsule, and leukotoxin. Vet Microbiol 1994;41:221-233.
14. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-685.
15. Harlow E, Lane D. Immunoblotting. In: Harlow E, Lane D, eds. Antibodies: a laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1988;506.
16. Locht C, Bertin P, Menozzi FD, et al. The filamentous haemagglutinin, a multifaceted adhesion produced by virulent Bordetella spp. Mol Microbiol 1993;9:653-660.
17. Miller JF, Roy CR, Falkow S. Analysis of Bordetella pertussis virulence gene regulation by use of transcriptional fusions in Escherichia coli. J Bacteriol 1989;171:6345-6348.
18. Novotny P, Kobisch M, Cownley K, et al. Evaluation of Bordetella bronchiseptica vaccines in specific-pathogen-free piglets with bacterial cell surface antigens in enzyme-linked immunosorbent assay. Infect Immun 1985;50:190-198.
19. Mooi FR, van Oirschot H, Heuvelman K, et al. Polymorphism in the Bordetella pertussis virulence factors P.69/pertactin and pertussis toxin in the Netherlands: temporal trends and evidence for vaccine-driven evolution. Infect Immun 1998;66:670-675.
20. Li J, Fairweather NF, Novotny P, et al. Cloning, nucleotide sequence and heterologous expression of the protective outer-membrane protein P.68 from Bordetella bronchiseptica. J Gen Microbiol 1992;138:1697-1705.
21. Li LJ, Dougan G, Novotny P, et al. P.70 pertactin, an outer-membrane protein from Bordetella parapertussis: cloning, nucleotide sequence, and surface expression in Escherichia coli. Mol Microbiol 1991;5:409-417.
22. Madoff LC, Michel JL, Gong EW, et al. Group B streptococci escape host immunity by deletion of tandem repeat elements of the alpha C protein. Proc Natl Acad Sci U S A 1996;93:4131-4136.
23. Brimer CD, Montie TC. Cloning and comparison of filC genes and identification of glycosylation in the flagelhn of Pseudomonas aeruginosa a-type strains J Bacteriol 1998;180:3209-3217.
24. Novotny P, Chubb AP, Cownley K, et al. Bordetella adenlyate cyclase: a genus specific protective antigen and virulence factor. Dev Biol Stand 1985;61:27-41.
25. Brennan MJ, Shahin RD. Pertussis antigens that abrogate bacterial adherence and elicit immunity. Am J Respir Crit Care Med 1996;154(suppl):145-149.
26. Roberts M, Cropley I, Chatfield S, et al. Protection of mice against respiratory Bordetella pertussis infection by intranasal immunization with P.69 and FHA. Vaccine 1993;11:866-872.
27. Boughton CR. Pertussis vaccines: acellular versus wholecell. Med J Aust 1996;164:564-566.
28. Greco D, Salmaso S, Mastrantonio P, et al. Controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. N Engl J Med 1996;334:341-348.
29. Khelef N, Danve B, Quentin-Miller MJ, et al. Bordetella pertussis and Bordetella parapertussis: two immunologically distinctive species. Infect Immun 1993;61:486-490.